Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 535

1.

Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.

Thoennissen NH, O'Kelly J, Lu D, Iwanski GB, La DT, Abbassi S, Leiter A, Karlan B, Mehta R, Koeffler HP.

Oncogene. 2010 Jan 14;29(2):285-96. doi: 10.1038/onc.2009.335. Epub 2009 Oct 26.

PMID:
19855437
2.

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.

Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.

Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.

PMID:
17869226
3.
4.

Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.

Jiang C, Guo J, Wang Z, Xiao B, Lee HJ, Lee EO, Kim SH, Lu J.

Breast Cancer Res. 2007;9(6):R77.

5.

Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.

Liu ZB, Hou YF, Zhu J, Hu DL, Jin W, Ou ZL, Di GH, Wu J, Shen ZZ, Shao ZM.

Oncogene. 2010 May 20;29(20):2996-3009. doi: 10.1038/onc.2010.70. Epub 2010 Mar 15.

PMID:
20228837
6.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
7.

[Involvement of epidermal growth factor receptor signaling pathway in tamoxifen resistance of MCF-7 cells].

Zhen LL, Zhu X, Zheng W, Wang XY, Wu ZY.

Ai Zheng. 2006 Jul;25(7):839-43. Chinese.

PMID:
16831274
9.

Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.

Rabi T, Wang L, Banerjee S.

Breast Cancer Res Treat. 2007 Jan;101(1):27-36.

PMID:
17028990
10.

Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.

Wang X, Yuan S, Wang J, Lin P, Liu G, Lu Y, Zhang J, Wang W, Wei Y.

Toxicol Appl Pharmacol. 2006 Sep 1;215(2):168-78. Epub 2006 Mar 23.

PMID:
16563451
11.

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.

Diaz R, Nguewa PA, Parrondo R, Perez-Stable C, Manrique I, Redrado M, Catena R, Collantes M, Peñuelas I, Díaz-González JA, Calvo A.

BMC Cancer. 2010 May 11;10:188. doi: 10.1186/1471-2407-10-188.

12.

A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.

Zhan Y, Zhang Y, Liu C, Zhang J, Smith WW, Wang N, Chen Y, Zheng L, He L.

Cancer Prev Res (Phila). 2012 Jun;5(6):864-73. doi: 10.1158/1940-6207.CAPR-11-0575. Epub 2012 Apr 11.

13.

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.

Mol Cancer Ther. 2009 Jun;8(6):1596-605. doi: 10.1158/1535-7163.MCT-08-1004. Epub 2009 Jun 9.

14.

Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.

Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC.

Cancer Lett. 2007 Apr 18;248(2):280-91. Epub 2006 Sep 11.

PMID:
16963181
15.

Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.

Lu Q, Zhang P, Zhang X, Chen J.

Int J Mol Med. 2009 Dec;24(6):773-80.

PMID:
19885617
16.

The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers.

Chung H, Jung JY, Cho SD, Hong KA, Kim HJ, Shin DH, Kim H, Kim HO, Shin DH, Lee HW, Jeong LS, Kong G.

Mol Cancer Ther. 2006 Mar;5(3):685-92.

18.

Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.

Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.

Int J Oncol. 2006 Apr;28(4):807-14.

PMID:
16525628
19.

Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.

Ray A, Nkhata KJ, Cleary MP.

Int J Oncol. 2007 Jun;30(6):1499-509.

PMID:
17487372
20.

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.

Thiantanawat A, Long BJ, Brodie AM.

Cancer Res. 2003 Nov 15;63(22):8037-50.

Supplemental Content

Support Center